Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Why the Healthcare Sector Warrants Concentrated Exposure

BY | ETF Database
10:59 am ET 05/13/26 | 6 VIEWS
  • Related Symbols
  • XLV
Sure, portfolio diversification may be important, but some equity sectors currently look a bit more promising than others. Key Takeaways: Diversification may be a valuable portfolio approach, but individual equity sectors like healthcare may warrant concentrated exposure. Healthcare is benefitting from a menagerie of favorable tailwinds, including strong M&A activity and compelling estimations for health spending in the near-term and long-term.  The State Street Health Care Select Sector SPDR ETF (XLV) is seeing significant inflows as investors look to gain exposure to this attractive sector. One such sector is healthcare. To be fair, those who have been keeping an eye on how this sector has been doing across the last year or so are likely not surprised to hear this. Towards the end of last year, M&A activity in the healthcare sector saw significant acceleration. Back at the end of December 2025, a J.P. Morgan report noted that the biotechnology sector in particular led the way in M&A deals year-to-date, as of October 27, 2025 at the time. Meanwhile, the health care equipment and pharmaceuticals sectors also put up impressive numbers.  Last year’s data is far from the only factor working in favor of the healthcare sector. A report from the Peterson Center on Healthcare projected health spending in the U.S. to reach $5.9 trillion by 2026. Going a step further, the report estimated that health spending will account for more than one fifth of the U.S. economy by 2033.  M&A activity and rising health spending are just two major drops in the bucket to support the rising tide of healthcare momentum. As the sector continues to adapt and evolve through AI adoption, healthcare growth could balloon even beyond present expectations. XLV Offers Distinct Access to Health Care GiantsFor those looking to capitalize on the opportunities in health care, a concentrated approach could prove to pay off. One way to do so is through a fund like the State Street Health Care Select Sector SPDR ETF (XLV A).  XLV offers straightforward access to the healthcare sector within the S&P 500 index. This includes companies engaged in biotechnology, pharmaceuticals, healthcare equipment, and far more.  It’s clear that this approach to focused healthcare companies is resonating with the investment community. ETFdb flows data shows that as of April 17, 2026, the fund has seen about $911 million in net inflows year to date.  For more news, information, and analysis, visit our Sector Investing Content Hub.

More Commentary

Navigating the Small-Cap ETF Disconnect
BY | ETF Database
6:43 am ET 05/13/26 | 12 VIEWS
ETF Prime: Space & AI Infrastructure in Focus
BY | ETF Database
10:26 am ET 05/13/26 | 14 VIEWS
This Semiconductor ETF Can Continue Sizzling
BY | ETF Database
9:48 am ET 05/13/26 | 16 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.